Abstract
Pathogenesis of cerebral oedema is considered. We also consider the various therapeutic measures available: mannitol, glycerol, dihydroxyacetone, hypertonic saline solution, barbiturate coma, cortisones, citicoline. An original technique of infusion via the carotid artery is illustrated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The brain cells do not require insulin, but the rest of the body’s cells do. In post-traumatic conditions, in the wide sense, increasing of catecholamines into circulation creates a pseudo-diabetic situation (due to activation of glucose-6 phosphatase), which should not be aggravated.
References
Berman IR, Rogers LA. Cerebral acidosis following increased intracranial pressure. Surg Gynecol Obstet. 1970;130:483.
Bachelard HS, Lewis LD, Ponten O, Siesjo BK. Mechanism activating glycolysis in the brain in arterial hypoxia. J Neurosurg. 1974;22:395.
Moruzzi G, Rossi CA, Rabbi A. Principi di Chimica biologica. VIII ed. Bologna: Tinarelli Editore; 1984. p. 418.
Alemanno F, Mayr O, Ragagni M, De Giorgi G. Edema cerebrale: la terapia osmotica nelle pratica clinica. Minerva Anestesiol. 1992;58(Suppl 1):239.
Ghelli F. Miglioramento della resistenza allo stress idrico in piante geneticamente modificate. Padua University, Faculty of Sciences MM.FF.NN, Department of Biology, First degree thesis in Biotechnology; 2007.
Biestro A, et al. Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol. Acta Neurochir. 1997;139:725.
Torelli L. Le dihydroxyacetone dans le traitment de l’oedéme cerebral. Agressologie. 1969;10:177.
Laborit H, Weber B, Ornellas MR, Baron C. Etude Pharmacologique de la dihydroxyacetone. Consequences therapeutiques. Agressologie. 1966;7(6):581.
Torelli L, Vindigni G. Il diidrossiacetone endovenoso come antiedema cerebrale. Acta Anaesth It. 1968;XIX:1241.
Alemanno F, Busato G, Porati U. Il diidrossiacetone per infusione endocarotidea nel trattamento dell’edema cerebrale. Acta Anaesth It. 1972;XXIII(4):283.
Serra I, Alberghina M, Viola M, Giuffrida AM. Effect of hypoxia on nucleic acid and protein synthesis in different brain regions. Neurochem Res. 1981;6(5):595.
Serra I, Alberghina M, Viola M, Mistretta A, Giuffrida AM. Effect of CDP-choline on the biosynthesis of nucleic acids and proteins in brain regions during hypoxia. Neurochem Res. 1981;6(6):607.
Petkov VD, Mosharrof AH, Kehayov R, Petkov VV, Konstantinova E, Getova D. Effect of CDP-choline on learning and memory processes in rodents. Methods Find Exp Clin Pharmacol. 1992;14(8):593.
Hazama T, Hasegawa T, Ueda S, Sakuma A. Evaluation of the effect of CDP-choline on poststroke hemiplegia employing a double-blind controlled trial. Assessed by a new rating scale for recovery in hemiplegia. Int J Neurosci. 1980;11(3):211.
Prough DS, Johnson JC, et al. Effects of hypertonic saline versus lactated Ringer’s solution on cerebral oxygen transport during resuscitation from hemorrhagic shock. J Neurosurg. 1986;64:627.
Gunnar V, Jonasson O, et al. Head injury and hemorragic shock: studies of the blood-brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution and dextrane-40. Surgery. 1988;103:398.
Vassar MJ, Perry CA, Holcroft JW. Analysis of potential risks associated with 7.5 % sodium chloride resuscitation of traumatic shock. Arch Surg. 1990;125:1309.
Vassar MJ, Perry CA, Gannaway WL, Holcroft JW. 7.5 % sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg. 1991;126:1065.
Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neur Surg Anesth. 1992;4:4.
Vasile B, Rasulo F, Candiani A, Latronico N. La fisiopatologia della sindrome da infusione di propofol: un nome semplice per una sindrome complessa. Intensive Care Med. 2003;1:1.
Parke TJ, Stevens JE, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five reports. BMJ. 1992;305:613.
Robert I, Schierhout G, Alderson P. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiatry. 1998;65:729.
Papadopulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrol. 2007;22:778.
Lecture APN. Aquaporin water channels. Biosci Rep. 2004;24:127.
Shakur H, Andrews P, et al. The Brain Trial: a randomized placebo controlled of a bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury. Trials. 2009;10:109.
Von Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931;72(1):74.
Saria A. Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after termal injury. Br J Pharmacol. 1984;82:217.
Yonehara N, Shibutani T, Inoki R. Contribution of substance P to heat-induced edema in rat paw. J Pharmacol Exp Ther. 1987;242(3):1071.
Nimmo AJ, Cernak I, Hath DL, Hu X, Bennett CJ, Vink R. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides. 2004;38:40.
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab. 2009;29(8):1388.
Further Reading
Bachelard HS. Specificity and kinetic properties of monosaccharide uptake into guinea-pig cerebral cortex in vitro. J Neuorochem. 1971;18:213.
Becker DP, Vries JK. The alleviation of increased intracranial pressure by chronic administration of osmotic agents. In: Brock M, Dietz H, editors. Intracranial pressure: experimental and clinical aspects. Berlin: Springer; 1972.
Brain Trauma Foundation. Guidelines for the management of severe head injury. Baltimore: Brain Trauma Foundation; 1995.
Diaz R, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298(20):2399.
Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol. 1987;72(3):236.
Laborit H. Les Régulations Métaboliques. Paris: Masson & Cie; 1965. p. 470.
Muizelaar JP, Lutz HA, Becker DP. Effect of mannitol on ICP and CBF correlation with pressure autoregolation in severely head impairments patients. J Neurosurg. 1984;61:700.
Nakayama S, Sibley L, et al. Small volume resuscitation with hypertonic saline during hemorragic shock. Circ Shock. 1984;13:149.
Pittis L, et al. Icp outcome in patients with severe head injury. In: Shulman K, Marmarou A, et al., editors. Intracranial pressure. Berlin: Springer; 1980.
Ranzini M, et al. Farmaci anti-edemigeni e mortalità a breve termine in pazienti anziani con ictus ischemico in fase acuta. G Gerontol. 2006;LIV:96.
Rosner MJ, Coley I. Cerebral perfusion pressure: a hemodynamic mechanism of mannitolo and the postmannitol hemogram. Neurosurgery. 1987;21:147.
Schulz J, Plesnila N, et al. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats. Acta Neurochir Suppl. 2000;76:137.
Pallares S, et al. Effects of intravenous infusion of a potassium-glucose-insulin on the electocardiographic signs of myocardial infarction. Am J Cardiol. 1962;9:166.
Pallares S, et al. The polarizing treatment for myocardial infarction. Am J Cardiol. 1969;24:607.
Takagi H, Saito T, Kitahara T, Mrii S, Ohwada T. Yada. The mechanism of ICP reducing effect of mannitol. In: Ishii S, Nagai H, Brock M, editors. Intracranial pressure. Berlin: Springer; 1983.
Towler PK, Bennett GS, Moore PK, Brain SD. Neurogenic oedema and vasoldilation: effect of a selective neuronal NO inhibitor. Neuroreport. 1998;9:1513.
Varriale L. RNA interference. http://www.molecularlab.it
Velasco IT, et al. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Phisiol. 1980;239:664.
Zweckberger K, Plesnila N. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. Neurosci Lett. 2009;454(2):115–7. https://doi.org/10.1016/j.neulet.2009.02.014. Epub 2009 Feb 11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alemanno, F. (2020). Cerebral Oedema. In: Alemanno, F. (eds) Biochemistry for Anesthesiologists and Intensivists. Springer, Cham. https://doi.org/10.1007/978-3-030-26721-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-26721-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26720-9
Online ISBN: 978-3-030-26721-6
eBook Packages: MedicineMedicine (R0)